FlowView develops AI-powered flow cytometry analysis software that automates the interpretation of complex multicolor data, enabling healthcare professionals to identify disease-specific cells with greater accuracy and speed. The platform addresses the challenge of manual data analysis in clinical settings, providing reliable insights for early cancer intervention and monitoring of inflammatory diseases.
Funding
$3.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Manual flow cytometry data analysis is complex, time-consuming, and prone to inconsistencies due to reliance on expert professionals for data interpretation. Traditional methods struggle to efficiently process high-dimensional datasets, leading to workflow bottlenecks and potential inaccuracies in identifying disease-specific cells.
Solution
FlowView provides an AI-powered flow cytometry analysis platform that automates the interpretation of complex multicolor data, enabling faster and more accurate identification of disease-specific cells. The cloud-based Software as a Service (SaaS) platform, Asudes, employs the patented Eclipse algorithm to simplify complex data into intuitive 2D visuals, making it accessible for healthcare professionals, researchers, and Clinical Research Organizations (CROs). By comparing data to control groups and delivering thorough analysis, FlowView streamlines workflows, reduces manual errors, and enhances diagnostic confidence. The platform facilitates better clinical operations, impactful research, and improved patient care through reliable clinical data.
Target Audience
The primary users are healthcare professionals, researchers, and Clinical Research Organizations (CROs) seeking to streamline flow cytometry data analysis, improve accuracy, and enhance patient outcomes.
Features
- AI-powered Eclipse algorithm for automated identification of disease-specific cells
- Cloud-based SaaS platform accessible for labs, hospitals, and research teams
- Simplifies complex multicolor flow cytometry data into easy-to-read 2D images
- Compares data to control groups for thorough analysis
- Intuitive interface for user-friendly operation
- High-dimensional data processing for comprehensive insights
- Deterministic AI approach ensuring reproducibility